oHSV2 Can Target Murine Colon Carcinoma by Altering the Immune Status of the Tumor Microenvironment and Inducing Specific Antitumor Immunity

Molecular Therapy - Oncolytics - United Kingdom
doi 10.1016/j.omto.2019.12.012